ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

NCT01001377 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1010
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen